Endovenous Therapy. Redefined.
We're developing innovative, endovascular solutions for the relief of chronic venous insufficiency.
With extensive experience in peripheral vascular catheter manufacturing and commercialization, our well-versed team is developing next-level technology for the treatment of chronic venous insufficiency (CVI). We're committed to providing safe, reliable, and economical clinical results through operational excellence and strong relationships with our physician partners.
Brady Hatcher, CEO
Brady Hatcher serves as Chief Executive Officer for Crossfire Medical. He's also the CEO and co-founder of Switchback Medical, a fast-growing contract manufacturer based in Minneapolis, MN. Prior to starting Crossfire in 2016, Brady served as Vice President of Operations and General Manager of Vention Medical - Minneapolis. Before joining Vention via acquisition in 2013, Brady co-founded and served as a Principal of Fast Forward Medical from 2007 through 2013.
Scott Nelson, CCO
Scott Nelson serves as Chief Commercial Officer for Crossfire Medical. Scott is also the co-founder of Joovv, a fast-growing direct-to-consumer medtech company that has been featured in mainstream outlets like FOX, ESPN, and the New York Times. He’s held sales and marketing leadership positions for some of the largest multi-nationals in the world including Medtronic, Covidien, Boston Scientific, and C.R. Bard. In his most recent role at Medtronic, Scott led U.S. downstream marketing for the $180M endovenous business.
Randy Beyreis, CTO
Randy Beyreis serves as Chief Technology Officer for Crossfire Medical. He's also the co-founder of Switchback Medical, a fast-growing contract manufacturer based in Minneapolis, MN. Prior to joining Crossfire in 2016, Randy served as Vice President of Product Development and Technology at Vention Medical – Minneapolis, where he joined via acquisition in 2013. Before his tenure at Vention, Randy co-founded and served as a Principal of Fast Forward Medical from 2007 through 2013.
If you have questions about what we're working on, complete the short form below and we'll be in touch soon.
We'll respond to your message within two business days.